These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6089686)

  • 1. Prevention of mycosis in granulocytopenic patients. A comparative study between nystatin and ketoconazole.
    Avilés A; Ambríz R; Escobedo J; Sinco A; Pizzuto J; Macotela E
    Arch Invest Med (Mex); 1984; 15(1):55-65. PubMed ID: 6089686
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of ketoconazole v nystatin in prevention of fungal infections in neutropenic patients.
    Jones PG; Kauffman CA; McAuliffe LS; Liepman MK; Bergman AG
    Arch Intern Med; 1984 Mar; 144(3):549-51. PubMed ID: 6322710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative trial of ketoconazole and nystatin for prevention of fungal infection in neutropenic patients treated in a protective environment.
    Shepp DH; Klosterman A; Siegel MS; Meyers JD
    J Infect Dis; 1985 Dec; 152(6):1257-63. PubMed ID: 3905986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial comparing ketoconazole and nystatin prophylactic therapy in neutropenic patients.
    Vogler WR; Malcom LG; Winton EF
    Cancer Invest; 1987; 5(4):267-73. PubMed ID: 3664330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of fungal infections with ketoconazole in cancer patients receiving cytostatic therapy].
    König HJ; Georgiou A; Kraft P; Mayer U
    Mycoses; 1988 Jun; 31(6):324-9. PubMed ID: 3173422
    [No Abstract]   [Full Text] [Related]  

  • 6. Ciprofloxacin for infection prophylaxis in granulocytopenic patients with acute leukemia.
    Cortellaro M; Cofrancesco E; Pasargiklian I; Bianchi R; Pozzoli E; Annaloro C; Ranzi ML; Mascheroni E; Polli N
    Haematologica; 1990; 75(6):541-5. PubMed ID: 2098296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prophylactic ketoconazole and nystatin on fungal flora.
    Kauffman CA; Jones PG; Bergman AG; McAuliffe LS; Liepman MK
    Mykosen; 1984 Apr; 27(4):165-72. PubMed ID: 6328295
    [No Abstract]   [Full Text] [Related]  

  • 8. Ketoconazole versus nystatin as prophylaxis against fungal infection for lymphoma patients receiving chemotherapy.
    Turhan A; Connors JM; Klimo P
    Am J Clin Oncol; 1987 Aug; 10(4):355-9. PubMed ID: 2441593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Opportunistic mycoses in hematology].
    Pizzuto J; López R; Morales M; Díaz Castillo LL; Amaro A; Butrón L; González Mendoza A
    Gac Med Mex; 1976 May; 111(5):411-20. PubMed ID: 964533
    [No Abstract]   [Full Text] [Related]  

  • 10. Prophylactic oral antibiotics in the management of acute leukaemia.
    Levi JA; Vincent PC; Jennis F; Lind DE; Gunz FW
    Med J Aust; 1973 May; 1(21):1025-9. PubMed ID: 4718495
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention and treatment of invasive mycoses in patients with neutropenia and bone marrow transplantation].
    Burgaleta C
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():31-7. PubMed ID: 9441303
    [No Abstract]   [Full Text] [Related]  

  • 12. Prophylaxis of mycotic infections in immunocompromised patients: a review of 27 reports and publications.
    Cauwenbergh G
    Drugs Exp Clin Res; 1986; 12(5):419-27. PubMed ID: 3522162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ketoconazole in the prevention of mycotic complications during cytostatic treatment of leukemias and lymphomas].
    Krcová V; Krc I; Kubis M; Mlcochová E; Podivínská I
    Vnitr Lek; 1985 Jun; 31(6):567-71. PubMed ID: 4036023
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of mycosis in granulocytopenic patients with prophylactic ketoconazole treatment.
    Brincker H
    Mykosen; 1983 May; 26(5):242-7. PubMed ID: 6308441
    [No Abstract]   [Full Text] [Related]  

  • 15. Antifungal topical therapy in oral chronic candidosis. A comparative study.
    Lopez-De-Blanc SA; Salati-De-Mugnolo N; Femopase FL; Benitez MB; Morelatto RA; Astrada-De-Verde L; Masih D
    Med Oral; 2002; 7(4):260-70. PubMed ID: 12134127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The granulocytopenic patient: another consideration for antimicrobial prophylaxis.
    Otis LL; Terezhalmy GT
    Oral Surg Oral Med Oral Pathol; 1985 Jul; 60(1):125-9. PubMed ID: 3162130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limits of antifungal prophylaxis by ketoconazole in leukemic patients.
    Mazzoni A; Fiorentini C; Cevenini R; Nanetti A
    Chemioterapia; 1985 Aug; 4(4):299-302. PubMed ID: 4053215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Infectious complications in malignant hematopoietic diseases under an incompletely protective regimen].
    Mociková K; Faber E; Svác J; Zaloudek F
    Vnitr Lek; 1987 Jul; 33(7):571-8. PubMed ID: 3660701
    [No Abstract]   [Full Text] [Related]  

  • 19. Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients.
    Winston DJ; Ho WG; Nakao SL; Gale RP; Champlin RE
    Am J Med; 1986 May; 80(5):884-90. PubMed ID: 3010716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic allograft rejection under quadruple immunosuppressive regimen with cyclosporine A in liver transplantation: incidence of viral and fungal infection.
    Fabregat J; Fradera R; Figueras J; Rafecas A; Torras J; Martinez LaCasa J; Baliellas C; Casais L; Jaurrieta E
    Transplant Proc; 1994 Oct; 26(5):2697-9. PubMed ID: 7940845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.